John Pasi

Professor

John Pasi

  • Vice President & Global Head of Haematology and Rare Blood Diseases
  • Roche Products Ltd
  • United Kingdom
  • Year elected: 2023

Types of Fellowship

  • Life Fellow

Areas of expertise

  • Haematology , haemostasis and thrombosis, gene and molecular therapy

BIO

John Pasi qualified in medicine from University of Birmingham in 1983 and subsequently undertook a PhD in Immunology. Moving to London in 1991 he completing his training in haematology as a Lecturer at the Royal Free Hospital. He was appointed as a consultant, specializing in haemostasis and thrombosis, at the Royal Free in 1993 and then moved to Leicester to take up the foundation Chair in Haematology in 1999. Since 2003 he has been Professor of Haemostasis and Thrombosis at QMUL.
 
His clinical practice today spans both adults and children and covers all aspects of haemostasis and thrombosis. He had been the Haemophilia Centre Director at Barts Health since 2007.
 
He has also been involved in the development of national policy and guideline formulation. Previously he was an advisor to the Parliamentary Health Select Committee and worked with the Department of Health on VTE prevention policy.
 
He is a member of NHS England Clinical Reference Group (GRG) for Inherited Bleeding Disorders, leads the link between the CRG and NIHR on research and co-chair of the ISTH Scientific and Standardization Committee on factor VIII, factor IX and rare coagulation disorders and the WFH Gene Therapy Roundtable.